Exact Mass: 571.4083962000001
Exact Mass Matches: 571.4083962000001
Found 180 metabolites which its exact mass value is equals to given mass value 571.4083962000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
LysoPC(22:4(7Z,10Z,13Z,16Z)/0:0)
LysoPC(22:4(7Z,10Z,13Z,16Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(22:4(7Z,10Z,13Z,16Z)), in particular, consists of one chain of adrenic acid at the C-1 position. The adrenic acid moiety is derived from animal fats. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. [HMDB] LysoPC(22:4(7Z,10Z,13Z,16Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(22:4(7Z,10Z,13Z,16Z)), in particular, consists of one chain of adrenic acid at the C-1 position. The adrenic acid moiety is derived from animal fats. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.
Ile Arg Lys Arg
Ile Lys Arg Arg
Ile Arg Arg Lys
Lys Ile Arg Arg
Lys Leu Arg Arg
Lys Arg Ile Arg
Lys Arg Leu Arg
Lys Arg Arg Ile
Lys Arg Arg Leu
Leu Lys Arg Arg
Leu Arg Lys Arg
Leu Arg Arg Lys
Arg Ile Lys Arg
Arg Ile Arg Lys
Arg Lys Ile Arg
Arg Lys Leu Arg
Arg Lys Arg Ile
Arg Lys Arg Leu
Arg Leu Lys Arg
Arg Leu Arg Lys
Arg Arg Ile Lys
Arg Arg Lys Ile
Arg Arg Lys Leu
Arg Arg Leu Lys
LysoPC(22:4/0:0)
HEXADECYL 2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-BETA-D-GLUCOPYRANOSIDE
N-[(3R,9R,10S)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide
N-[(3R,9R,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide
N-[(3R,9S,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide
N-[(3S,9S,10S)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide
[3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
2-aminoethyl [3-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoxy]-2-hydroxypropyl] hydrogen phosphate
[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-hexanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
2-[3-octanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxyhexadec-7-enoyl]amino]pentadeca-4,8-diene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxynonadec-9-enoyl]amino]dodeca-4,8-diene-1-sulfonic acid
(E)-3-hydroxy-2-[[(10Z,12Z)-2-hydroxyoctadeca-10,12-dienoyl]amino]tridec-4-ene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-(2-hydroxytetradecanoylamino)heptadeca-4,8,12-triene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-(2-hydroxytridecanoylamino)octadeca-4,8,12-triene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-(2-hydroxypentadecanoylamino)hexadeca-4,8,12-triene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-(2-hydroxyhexadecanoylamino)pentadeca-4,8,12-triene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]octadeca-4,8-diene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]nonadeca-4,8-diene-1-sulfonic acid
(E)-3-hydroxy-2-[[(11Z,14Z)-2-hydroxyicosa-11,14-dienoyl]amino]undec-4-ene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxypentadec-9-enoyl]amino]hexadeca-4,8-diene-1-sulfonic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propan-2-yl] nonanoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
(E)-3-hydroxy-2-[[(4Z,7Z)-2-hydroxyhexadeca-4,7-dienoyl]amino]pentadec-4-ene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]heptadeca-4,8-diene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-(2-hydroxydodecanoylamino)nonadeca-4,8,12-triene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxyoctadec-11-enoyl]amino]trideca-4,8-diene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-(2-hydroxyheptadecanoylamino)tetradeca-4,8,12-triene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(undecanoylamino)henicosa-4,8-diene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(icosanoylamino)dodeca-4,8-diene-1-sulfonic acid
(E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxydec-4-ene-1-sulfonic acid
2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxydecane-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(tetradecanoylamino)octadeca-4,8-diene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(pentadecanoylamino)heptadeca-4,8-diene-1-sulfonic acid
3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]tetradecane-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(octadecanoylamino)tetradeca-4,8-diene-1-sulfonic acid
(4E,8E)-2-(dodecanoylamino)-3-hydroxyicosa-4,8-diene-1-sulfonic acid
3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]tridecane-1-sulfonic acid
(4E,8E)-2-(hexadecanoylamino)-3-hydroxyhexadeca-4,8-diene-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]nonadec-4-ene-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]tetradec-4-ene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(tridecanoylamino)nonadeca-4,8-diene-1-sulfonic acid
(4E,8E)-2-(heptadecanoylamino)-3-hydroxypentadeca-4,8-diene-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]heptadec-4-ene-1-sulfonic acid
(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxypentadec-4-ene-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]dodec-4-ene-1-sulfonic acid
3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]dodecane-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]tridec-4-ene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(nonadecanoylamino)trideca-4,8-diene-1-sulfonic acid
2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxypentadecane-1-sulfonic acid
(E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxyundec-4-ene-1-sulfonic acid
(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyhexadec-4-ene-1-sulfonic acid
(4E,8E)-2-(decanoylamino)-3-hydroxydocosa-4,8-diene-1-sulfonic acid
2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyundecane-1-sulfonic acid
2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxyhexadecane-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]octadec-4-ene-1-sulfonic acid
4-(3-Heptanoyloxy-2-pentadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Acetyloxy-2-icosanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Butanoyloxy-2-octadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Octanoyloxy-2-tetradecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Nonanoyloxy-2-tridecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Nonadecanoyloxy-3-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Heptadecanoyloxy-3-pentanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Hexadecanoyloxy-3-hexanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-[2,3-Di(undecanoyloxy)propoxy]-2-(trimethylazaniumyl)butanoate
4-(3-Decanoyloxy-2-dodecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
[2-butanoyloxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propan-2-yl] pentanoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]propan-2-yl] propanoate
[2-acetyloxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] heptanoate
4-(2-Decanoyloxy-3-dodecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadeca-4,8-dien-2-yl]decanamide
N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadeca-4,6-dien-2-yl]decanamide
2-[[(E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxynon-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxynonoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
1-[(7Z,10Z,13Z,16Z)-docosatetraenoyl]-sn-glycero-3-phosphocholine
A lysophosphatidylcholine 22:4 in which the acyl group is specified as (7Z,10Z,13Z,16Z)-docosatetraenoyl and is located at position 1.
lysophosphatidylcholine 22:4
A lysophosphatidylcholine in which the acyl group (position not specified) contains 22 carbons and 4 double bonds.
lysophosphatidylcholine (22:4/0:0)
A lysophosphatidylcholine 22:4 in which the docosatetraenoyl group is located at position 1.
MePC(21:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved